RE:RE:RE:From Linkedin My long time away , weekend update.
Not much to add actually.
fastrack5 , brought into focus the relevant information.
regarding the $150million shelf perspectus.
Nothing new, what so ever about that.
They have had that running for many years.
like all legal requirements, there are dates of completion of the notice.
The renewal is not new $$, just a continuation of previous.
meaning they have the ability to issue up to $150 million in new shares.
Does not mean they will, but can.
other than that, it is a wait & see time.
The ducks are lining up. So we wait.
Regarding the lack of volume = lack of interest?
double equally important views on that.
One, few are selling. Waiting for news.
Two , few are buying waiting for news.
The day traders have moved on.
The existing institutions & insiders are neither buying or selling, waiting for news.
anyone , understanding the dynamics of onc & Pelareorep , appreciate the importance of the upcoming next few months.
The recent FDA meeting report was favourable.
They are lined up to start the panc cancer early next year.
The only open end, is the O.S. Results from the MBc bracelet trial.
That event could trigger, licensing deal, buyout or similar.
stay Tuned.